ES2609831T3 - Método y agente para la detección de drogas en bebidas - Google Patents

Método y agente para la detección de drogas en bebidas Download PDF

Info

Publication number
ES2609831T3
ES2609831T3 ES11743099.1T ES11743099T ES2609831T3 ES 2609831 T3 ES2609831 T3 ES 2609831T3 ES 11743099 T ES11743099 T ES 11743099T ES 2609831 T3 ES2609831 T3 ES 2609831T3
Authority
ES
Spain
Prior art keywords
pharmaceutical form
less
drink
fcf
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11743099.1T
Other languages
English (en)
Spanish (es)
Inventor
Catherine Herry
Pauline Contamin
Emmanuel Dupau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Application granted granted Critical
Publication of ES2609831T3 publication Critical patent/ES2609831T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D7/00—Indicating measured values
    • G01D7/005—Indication of measured value by colour change
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES11743099.1T 2010-07-06 2011-07-05 Método y agente para la detección de drogas en bebidas Active ES2609831T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1055490 2010-07-06
FR1055490A FR2962550B1 (fr) 2010-07-06 2010-07-06 Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode
PCT/FR2011/051600 WO2012010765A1 (fr) 2010-07-06 2011-07-05 Methode et agent pour la detection de drogues dans les boisson

Publications (1)

Publication Number Publication Date
ES2609831T3 true ES2609831T3 (es) 2017-04-24

Family

ID=43587415

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11743099.1T Active ES2609831T3 (es) 2010-07-06 2011-07-05 Método y agente para la detección de drogas en bebidas

Country Status (13)

Country Link
US (1) US20130098286A1 (enExample)
EP (1) EP2591350B1 (enExample)
JP (1) JP5916723B2 (enExample)
KR (2) KR20130091321A (enExample)
CN (1) CN103119435A (enExample)
AU (1) AU2011281482B2 (enExample)
CA (1) CA2802402A1 (enExample)
ES (1) ES2609831T3 (enExample)
FR (1) FR2962550B1 (enExample)
IL (1) IL223886B (enExample)
MX (1) MX344783B (enExample)
WO (1) WO2012010765A1 (enExample)
ZA (1) ZA201300099B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104237224A (zh) * 2014-10-14 2014-12-24 厦门奥亚仪器有限公司 苯二氮卓的快速检测方法及其操作器皿组合
US20220202742A1 (en) * 2019-05-07 2022-06-30 Clexio Biosciences Ltd. Dosage forms for preventing drug-facilitated assault
US20220175719A1 (en) * 2020-10-24 2022-06-09 Mason Cave Dissolvable thc beverage tablet production method
US20220241238A1 (en) * 2020-10-24 2022-08-04 Michael Roth Method for forming a beverage with a dissolvable thc tablet
CN115112582B (zh) * 2022-05-19 2024-08-09 西南科技大学 一种去甲芬太尼及芬太尼的检测试剂盒及其检测方法
CN117654708A (zh) * 2023-10-16 2024-03-08 杭州德望纳米科技有限公司 一种基于球磨实验改变蛇纹石粒度分级方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157662A (en) * 1966-08-08 1969-07-09 Codex S A Improvements in or relating to Pharmaceutical Compositions
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
FR2787715B1 (fr) * 1998-12-23 2002-05-10 Synthelabo Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables
FR2790387B1 (fr) 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
WO2001058424A1 (en) * 2000-02-09 2001-08-16 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Floating drug delivery composition
US6617123B1 (en) * 2000-06-29 2003-09-09 Jack V. Smith Method for detection of 4-hydroxybutyric acid and its precursor(s) in fluids
ITMI20011446A1 (it) * 2001-07-06 2003-01-06 Altergon Sa Composizioni farmaceutiche di principi attivi suscettibili di somministrazione illecita
US20030044989A1 (en) * 2001-09-04 2003-03-06 Guerra Francisco Javier Apparatus and method for testing a beverage for a clandestine illicit substance
FR2829933B3 (fr) * 2001-09-21 2004-03-12 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
FR2829932B1 (fr) * 2001-09-21 2006-11-24 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs et produit obtenu
FR2831820B1 (fr) 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
US20080102482A1 (en) 2003-12-19 2008-05-01 Stanley Irwin Grossman Apparatus for Detecting Drugs in a Beverage
WO2008033351A2 (en) * 2006-09-11 2008-03-20 Theraquest Biosciences, Inc. Multimodal abuse resistant and extended release formulations
JP2009256295A (ja) * 2008-04-11 2009-11-05 Kosumedei Seiyaku Kk 化粧用粘着シート
JP5059678B2 (ja) * 2008-04-18 2012-10-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 着色固形製剤およびその製造方法
FR2962331B1 (fr) * 2010-07-06 2020-04-24 Ethypharm Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre

Also Published As

Publication number Publication date
WO2012010765A1 (fr) 2012-01-26
KR20130091321A (ko) 2013-08-16
CN103119435A (zh) 2013-05-22
AU2011281482A1 (en) 2013-01-17
KR101957657B1 (ko) 2019-03-12
US20130098286A1 (en) 2013-04-25
JP5916723B2 (ja) 2016-05-11
FR2962550A1 (fr) 2012-01-13
FR2962550B1 (fr) 2013-06-14
CA2802402A1 (fr) 2012-01-26
ZA201300099B (en) 2014-03-26
EP2591350B1 (fr) 2016-10-26
KR20180080374A (ko) 2018-07-11
AU2011281482B2 (en) 2015-10-01
EP2591350A1 (fr) 2013-05-15
JP2013530206A (ja) 2013-07-25
IL223886B (en) 2018-03-29
MX344783B (es) 2017-01-06
MX2012015103A (es) 2013-05-28

Similar Documents

Publication Publication Date Title
US12396979B2 (en) Rapid disperse dosage form
ES2761407T3 (es) Forma de dosificación rápidamente dispersable de topiramato
ES2739888T3 (es) Composiciones y comprimidos farmacéuticos con recubrimiento compresible y métodos de fabricación
ES2609831T3 (es) Método y agente para la detección de drogas en bebidas
ES2409347T3 (es) Composiciones farmacéuticas de sabor enmascarado con agentes porogénicos gastrosolubles
ES2667944T3 (es) Gránulos y comprimidos orodispersables que contienen oxicodona
ES2944311T3 (es) Formulaciones de fenilacetato de L-ornitina
ES2582453T3 (es) Forma farmacéutica oral sólida contra el uso indebido y dotada de un perfil específico de liberación modificada
US9669009B2 (en) Rapid disperse dosage form containing levetiracetam
JP6445559B2 (ja) タダラフィルを含む口腔内崩壊フィルム製剤およびその製造方法
US8962022B2 (en) Pharmaceutical compositions comprising an active substance from the substituted benzhydrylpiperazine family
US20110212171A1 (en) Taste masked topiramate composition and an orally disintegrating tablet comprising the same
ES2633496T3 (es) Composiciones farmacéuticas que comprenden everolimus
AU2018202002A1 (en) Methods and compositions for treatment of attention deficit disorder
ES2852899T3 (es) Formulaciones estabilizadas de molindona
Sarkar et al. Solid dispersion tablets in improving oral bioavailability of poorly soluble drugs
JP5818219B2 (ja) ６，７−不飽和−７−カルバモイルモルヒナン誘導体含有製剤
RU2021102950A (ru) Твердые фармацевтические композиции для лечения вируса гепатита с
TR201801650T1 (tr) Kontrollü salim propi̇veri̇n formülasyonlari
WO2017013106A1 (en) Pharmaceutical formulations of dabigatran free base
US10022331B2 (en) Coating agent for solid preparation, and film and coated solid preparation formed therewith
KR20250025708A (ko) 캡 의존성 엔도뉴클레아제 억제제를 포함하는 약학 조성물
ES2818249T3 (es) Composición farmacéutica que comprende un agente antipsicótico atípico y método para su preparación
CN108601742A (zh) 具有改善的吸湿性的卡维地洛速释制剂
TR201606697A2 (tr) Dabi̇gatranin yeni̇ oral farmasöti̇k formülasyonlari